全文获取类型
收费全文 | 18921篇 |
免费 | 1767篇 |
国内免费 | 43篇 |
专业分类
耳鼻咽喉 | 163篇 |
儿科学 | 502篇 |
妇产科学 | 336篇 |
基础医学 | 2782篇 |
口腔科学 | 409篇 |
临床医学 | 2230篇 |
内科学 | 4009篇 |
皮肤病学 | 436篇 |
神经病学 | 1530篇 |
特种医学 | 504篇 |
外科学 | 3210篇 |
综合类 | 407篇 |
一般理论 | 13篇 |
预防医学 | 1625篇 |
眼科学 | 271篇 |
药学 | 1298篇 |
中国医学 | 15篇 |
肿瘤学 | 991篇 |
出版年
2021年 | 257篇 |
2020年 | 189篇 |
2019年 | 288篇 |
2018年 | 275篇 |
2017年 | 266篇 |
2016年 | 286篇 |
2015年 | 304篇 |
2014年 | 419篇 |
2013年 | 595篇 |
2012年 | 956篇 |
2011年 | 915篇 |
2010年 | 490篇 |
2009年 | 497篇 |
2008年 | 783篇 |
2007年 | 836篇 |
2006年 | 833篇 |
2005年 | 829篇 |
2004年 | 768篇 |
2003年 | 760篇 |
2002年 | 696篇 |
2001年 | 571篇 |
2000年 | 672篇 |
1999年 | 533篇 |
1998年 | 233篇 |
1997年 | 207篇 |
1996年 | 199篇 |
1995年 | 165篇 |
1994年 | 159篇 |
1993年 | 168篇 |
1992年 | 487篇 |
1991年 | 463篇 |
1990年 | 404篇 |
1989年 | 401篇 |
1988年 | 396篇 |
1987年 | 367篇 |
1986年 | 360篇 |
1985年 | 328篇 |
1984年 | 320篇 |
1983年 | 225篇 |
1982年 | 147篇 |
1981年 | 146篇 |
1980年 | 136篇 |
1979年 | 265篇 |
1978年 | 163篇 |
1977年 | 132篇 |
1976年 | 138篇 |
1974年 | 168篇 |
1973年 | 167篇 |
1972年 | 157篇 |
1971年 | 123篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects 总被引:2,自引:0,他引:2
Seven normal subjects received 0.25 mg/kg D-amphetamine orally, both after an overnight fast and again after a standard breakfast. Plasma levels, subjective and cardiovascular effects, and observer-rated activation were assessed hourly for 5 hr. Food did not affect amphetamine levels. Plasma levels peaked at 2-3 hr. Maximum cardiovascular effects generally occurred at 1 hr, whereas maximum behavioral and subjective effects occurred at 2 hr. Subjective and behavioral effects declined thereafter, in spite of substantial amphetamine levels. A separate group of 8 subjects received 0.5 mg/kg D-amphetamine orally. Plasma levels, subjective and cardiovascular effects, and activation ratings were assessed hourly for 4 hr. Maximum plasma levels were approximately twice those seen in the first group. In this case, plasma levels peaked at 3-4 hr; blood pressure and subjective and behavioral effects were all maximal at 2-3 hr and were declining by 4 hr, in spite of stable or rising plasma levels. 相似文献
22.
23.
C. J. Bowden W. D. Figg N. A. Dawson O. Sartor R. J. Bitton M. S. Weinberger Donna Headlee Eddie Reed C. E. Myers M. R. Cooper 《Cancer chemotherapy and pharmacology》1996,39(1-2):1-8
Introduction: Suramin is a synthetic polysulfonated naphthylurea which has been used for the treatment of African trypanosomiasis and onchocerciasis,
but since the mid-1980s has received attention as a possible antiretroviral and antineoplastic agent. Objective: This clinical trial of suramin was undertaken as a phase I/II study in patients with hormone-refractory prostate cancer,
with the hypothesis that the intensity of therapy with suramin could be increased significantly if measures were undertaken
to maintain the plasma concentrations of the drug under 300 μg/ml. Methods: We report the clinical results of this trial, wherein patients were treated at three different targeted plasma suramin concentrations
(275, 215 and 175 μg/ml) for varying periods of time (2, 4 or 8 weeks), with delivery of the drug by continuous intravenous
infusion. Results: The major toxicity observed in this trial was neurologic, consisting of a motor and sensory peripheral neuropathy that resulted
in both paresis and paralysis of the limbs. Nearly all of this severe (CTEP grade III, IV) neurologic toxicity was observed
in the patients treated at a plasma suramin concentration of 275 μg/ml for 4 or more weeks. A single patient treated at 215 μg/ml
for 8 weeks developed moderate (CTEP grade III) proximal lower extremity weakness, and no patient treated at 175 μg/ml developed
this toxicity. The second most common toxicity observed was infection of the central venous catheter. The overall response
rate for all of the evaluable patients was 17% (13 of 75 patients). In addition, prostate-specific antigen (PSA)-defined responses
were observed in six patients receiving therapy at 175 μg/ml, but these responses were confounded by cessation of therapy
with flutamide during suramin treatment. Conclusions: In summary, although plasma suramin concentrations were maintained below 300 μg/ml, neurologic toxicity nonetheless occurred
with high frequency in patients treated at 275 μg/ml for 4 or more weeks. Therapy at 215 and 175 μg/ml was in general well
tolerated, but central venous catheter-related infection, as well as the inconvenience and expense of continuous infusional
therapy, make this method of drug delivery impractical. Only moderate antitumor activity was observed during this trial, but
it is possible that both continuation of flutamide and flutamide withdrawal during suramin therapy confounded the assessment
of suramin’s activity in hormone-refractory prostate cancer.
Received: 9 June 1995/Accepted: 18 March 1996 相似文献
24.
A stratified sample of normal infants born at term at Johannesburg Hospital, who attended the hospital for a routine 6-week follow-up visit, were selected to include 43 infants who were exclusively breast-fed, 42 fed a low-sodium formula and 39 fed a high-sodium formula (greater than 10 mmol sodium/l). Dynamic skinfold thickness measurements (DSTM), designed to assess the amount of interstitial fluid, were performed on each infant by the application of a skinfold caliper for a 3-second sampling period at two sites. The curves generated by these applications were recorded and analysed by microcomputer. There were no differences between any of the feeding groups for DSTM measurements of blood pressure suggesting that the range of sodium ingested by these groups of infants had no significant effects on extracellular water content. However, using multiple linear regression, both DSTM and blood pressure were best predicted by body weight and not by age or any other anthropometric measurement. Thus the normal postnatal decrease in extracellular fluid volume and increase in blood pressure appears to be most closely related to an increase in body weight. 相似文献
25.
26.
27.
Using data from the National Health and Nutrition Examination Survey (NHANES II) 1976-1980, we demonstrate how cross-sectional total serum cholesterol surveillance data can be used by an individual to assess current and future personal cholesterol risk status. We propose statistical models, based on a person's current measured cholesterol level and the relationship between cross-sectional age and cholesterol percentile estimates, that will allow prediction of future cholesterol levels or the age at which specified cholesterol risk levels will be reached if no cholesterol-altering intervention is taken. These models incorporate the observed variation in the NHANES II data and expected intraperson biological variation and intralaboratory analytical variation. We illustrate the adequacy of the models using data from the longitudinal Framingham Study. 相似文献
28.
David Cooper 《Australian and New Zealand journal of public health》1986,10(3):294-306
This paper reports on five families whose parents described the stress arising from their child's disability and the additional stress and reward of participation in a Conductive Education program. The reports support the Conductive Education thesis, that children with physical disabilities respond well to integrated management which weaves medical insights and therapeutic practice into the fabric of daily life through a program which has an educational rather than a therapeutic bias. Parents also appreciate personal support from a non-intimidating, professionally comprehensive resource. An attempt was made to identify the elements which produced parental self-confidence and family cohesion. 相似文献
29.
K Kuwaki C Knosalla F J M F Dor B Gollackner Y-L Tseng S Houser D K C Cooper 《The Journal of heart and lung transplantation》2005,24(1):92-94
Troponin T levels have been monitored in baboons (n = 8) undergoing pig heterotopic heart transplantation, and correlated with a decrease in graft contractions and graft survival. Pig heart graft survival was from 12 to 139 days (mean 45, median 33), and graft failure was associated with predominant thrombotic microangiopathy and ischemia, with focal hemorrhage, and edema. An increase in troponin T levels 5 to 6 days before graft failure correlated closely with diminished graft contractions. An increase in troponin T was a reliable indicator that graft dysfunction was occurring. 相似文献
30.
Richard M. Cooper 《Journal canadien d'anesthésie》2007,54(1):54-57
PURPOSE: Two cases are presented wherein the GlideScope videolaryngoscope (GVL) facilitated laryngeal exposure and successful endotracheal intubation, but resulted in pharyngeal injury. CLINICAL FEATURES: GlideScope videolaryngoscopy was performed in two female patients, whose airways were anticipated to present difficulties for direct laryngoscopy. In the first case, following induction of anesthesia, moderate difficulty was encountered in directing the endotracheal tube (ETT) into the patient's larynx. In the second case, minimal difficulty with the GVL was experienced, and no problems were identified with airway instrumentation until the drapes covering the patient's face were removed. In both instances, the ETT had passed through the right palatopharyngeal arch, requiring suturing in the first patient, and electrocautery in the second patient. CONCLUSION: There have been no previously published reports of injuries related to GlideScope laryngoscopy, but perforation of the palatopharyngeal arch occurring in two patients demonstrates a rare but potentially important complication of the GVL. Strategies to minimize this complication are considered. 相似文献